Citation Impact
Citing Papers
Gene Expression Signatures for Tumor Progression, Tumor Subtype, and Tumor Thickness in Laser-Microdissected Melanoma Tissues
2007
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 Standout
Pharmacokinetics and Pharmacodynamics of IFN-β1a in Healthy Volunteers
2000
The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States
2008 Standout
Screening for skin cancer
2001
Epidemiology of Melanoma and Nonmelanoma Skin Cancer—The Role of Sunlight
2009
Cancer statistics, 2017
2017 Standout
Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual
2017 Standout
Melanoma Patients with an Unknown Primary Tumor Site Have a Better Outcome than Those with a Known Primary Following Therapeutic Lymph Node Dissection for Macroscopic (Clinically Palpable) Nodal Disease
2014
Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials
2003
Single‐institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting
2010 StandoutNobel
Verlauf der psychosozialen Belastung und gesundheitsbezogenen Lebensqualität bei Patienten verschiedener Altersgruppen in der onkologischen Rehabilitation
2009
Immunological Insights from Patients Undergoing Surgery on Ipilimumab for Metastatic Melanoma
2013 StandoutNobel
Metastatic melanoma to lymph nodes in patients with unknown primary sites
2006
Prognostic Factors That Determine the Long-Term Survival of Patients with Unresectable Metastatic Melanoma
2008
Cutaneous melanoma in Asian‐Americans
2008
Clinical translation of angiogenesis inhibitors
2002 Standout
Androgen blockade enhances response to melanoma vaccine 1 1This work was supported in part by a Young Investigator Award from the American Society of Clinical Oncology (to Dr. Hsueh). Presented at the annual meeting of the American Society of Clinical Oncology, San Francisco, May 12–15, 2001.
2003
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
ESPEN guideline: Clinical nutrition in surgery
2017 Standout
Problems in defining cutoff points of continuous prognostic factors: Example of tumor thickness in primary cutaneous melanoma
1997
Exploiting the critical perioperative period to improve long-term cancer outcomes
2015
Multicenter evaluation of the analytical and clinical performance of the Elecsys ® S100 immunoassay in patients with malignant melanoma
2005
Dermatologist-level classification of skin cancer with deep neural networks
2017 StandoutNature
A Framework for Operational Modelling of Hospital Resources
2002
A new American Joint Committee on Cancer staging system for cutaneous melanoma
2000
Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM‐CSF as adjuvant
2001
Stage-IV Melanoma and Pulmonary Metastases: Factors Predictive of Survival
2007
Sentinel-Node Biopsy or Nodal Observation in Melanoma
2006 Standout
Angiogenesis: an organizing principle for drug discovery?
2007 Standout
In Vivo and In Vitro Induction of MxA Protein in Peripheral Blood Mononuclear Cells from Patients Chronically Infected with Hepatitis C Virus
1999
Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
2013 Standout
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.
1997
The incidence of second primary invasive melanoma in Queensland, 1982–2003
2007
Osteosarcoma treatment – Where do we stand? A state of the art review
2013 Standout
CLASSIFICATION AND STAGING OF MELANOMA
1998
Diagnostic and therapeutic management of cancer of an unknown primary
2003
Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)
2000
Anti–CTLA-4 Antibody Therapy: Immune Monitoring During Clinical Development of a Novel Immunotherapy
2010 StandoutNobel
Mechanistic insight into diabetic wounds: Pathogenesis, molecular targets and treatment strategies to pace wound healing
2019 Standout
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
CTLA-4 blockade increases antigen-specific CD8+ T cells in prevaccinated patients with melanoma: three cases
2011 StandoutNobel
Targeting RAS signalling pathways in cancer therapy
2003 Standout
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016
2016
A Single-Institution Validation of the AJCC Staging System for Stage IV Melanoma
2008
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
2013 Standout
The cost of dichotomising continuous variables
2006 Standout
Brain and leptomeningeal metastases from cutaneous melanoma: Survival outcomes based on clinical features
2008
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
2017 Standout
Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study
2008
MicroRNA expression profiles classify human cancers
2005 StandoutNatureNobel
De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival
2016
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma
2010 StandoutNobel
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
2009 Standout
Solitary Melanoma Confined to the Dermal and/or Subcutaneous Tissue
2000
Long-term results of the Spanish Protocol SO-95 for the treatment of non-metastatic high-grade osteosarcoma of the extremities in children
2009
Inhibition of HIV replication: A powerful antiviral strategy by IFN-β gene delivery in CD4+ cells
2007 StandoutNobel
Immune checkpoint inhibitors: recent progress and potential biomarkers
2018 Standout
Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature
2010
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Can immunohistochemical markers and mitotic rate improve prognostic precision in patients with primary melanoma?
1999
Epidemiology of Cutaneous Melanoma in Germany and Worldwide
2001
Gender-Related Differences in Outcome for Melanoma Patients
2006
Risk Stratification for In-Hospital Mortality in Acutely Decompensated Heart Failure<SUBTITLE>Classification and Regression Tree Analysis</SUBTITLE>
2005
Diabetic foot ulcers
2013
Interferon-inducible antiviral effectors
2008 Standout
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
2020 Standout
Current methods of the U.S. Preventive Services Task Force
2001 Standout
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
2012 Standout
Operating room planning and scheduling: A literature review
2009 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials
2008
Foot-and-Mouth Disease
2004 Standout
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
2001 Standout
Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.
1997
Predicting ten-year survival of patients with primary cutaneous melanoma
1997
Systemic IFN-β gene therapy results in long-term survival in mice with established colorectal liver metastases
2001
A systems modelling approach for the prevention and treatment of diabetic retinopathy
2003
Breslow thickness and Clark level in melanoma
2000
Improved Survival After Lymphadenectomy for Nodal Metastasis From an Unknown Primary Melanoma
2008
Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
2000
Interferon-β gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice
1998
Pathologic and Clinical Features Influencing Outcome of Thin Cutaneous Melanoma: Correlation with Newly Proposed Staging System
2000
Modelling for the planning and management of bed capacities in hospitals
2002
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
2001 Standout
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
Prognostic Factors in Metastatic Melanoma: A Pooled Analysis of Eastern Cooperative Oncology Group Trials
2000
Operations Research in Healthcare: a survey
2010 Standout
Electrogenerated Chemiluminescence and Its Biorelated Applications
2008 Standout
Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule.
1999
Automatic Skin Cancer Detection in Dermoscopy Images Based on Ensemble Lightweight Deep Learning Network
2020 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 Blockade
2017 StandoutNobel
UV Radiation and the Skin
2013 Standout
Computer Aided Diagnostic Support System for Skin Cancer: A Review of Techniques and Algorithms
2013
Regression Modeling Strategies
2015 Standout
Works of Waltraud Stroebel being referenced
Pharmacodynamics of Recombinant IFN-β During Long-Term Treatment of Malignant Melanoma
1996
Patterns of Local Horizontal Spread of Melanomas
1999
Psychosoziale Belastung und subjektives Erleben von Melanompatienten in der ambulanten Nachsorge
2003
Extent and consequences of physician delay in the diagnosis of acral melanoma
1998
Primary cutaneous melanoma. Prognostic classification of anatomic location
1995
Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients
1995
Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of clark's level for prognostic classification
1995
Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment
1999
Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma
1997
Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma
2000
Prospective Evaluation of a Follow-Up Schedule in Cutaneous Melanoma Patients: Recommendations for an Effective Follow-Up Strategy
2003
Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors.
1997
Significance of serum protein S100 levels in screening for melanoma metastasis: does protein S100 enable early detection of melanoma recurrence?
2000
Prolonged survival of 2 years or longer for patients with disseminated melanoma
1997